Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Acorda Therapeutics Inc    ACOR   US00484M1062

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/13/2015 04/14/2015 04/15/2015 04/16/2015 04/17/2015 Date
34.82(c) 34.2(c) 35.18(c) 34.68(c) 34.49(c) Last
411 982 369 834 581 152 384 508 623 511 Volume
+1.04% -1.78% +2.87% -1.42% -0.55% Change
More quotes
Financials ($)
Sales 2015 454 M
EBIT 2015 4,60 M
Net income 2015 -23,0 M
Finance 2015 25,5 M
Yield 2015 -
Sales 2016 513 M
EBIT 2016 51,6 M
Net income 2016 -15,0 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 3,18x
Capi. / Sales 2016 2,86x
Capitalization 1 468 M
More Financials
Company
Acorda Therapeutics, Inc. engages in the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the nervous system.The company's two main products are Ampyra and Zanaflex... 
Sector
Biotechnology & Medical Research
Calendar
04/22 | 07:30amPresentation
More about the company
Surperformance© ratings of Acorda Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ACORDA THERAPEUTICS INC
04/08 ACORDA THERAPEUTICS : Patent Issued for Carbonate Prodrugs and Methods of Using ..
04/07DJKYLE BASS'S NEW TACK : Dispute the Patent, Short the Stock
04/07DJHedge-Fund Manager Challenges Jazz Pharmaceuticals Patent
04/02 ACORDA THERAPEUTICS : Assigned Patent
03/25 ACORDA THERAPEUTICS : Rings NASDAQ Opening Bell to Mark 20th Anniversary
03/18 ACORDA THERAPEUTICS : to Present New Analyses of Cimaglermin alfa GGF2 Data at t..
03/16 ACORDA THERAPEUTICS : Rings NASDAQ Opening Bell to Mark 20th Anniversary
03/13 ACORDA THERAPEUTICS : ACOR) to Ring The Nasdaq Stock Market Opening Bell
More news
Sector news : Bio Therapeutic Drugs
04/17 INCYTE : Emerging Development Pipeline Described in Eleven Abstracts at 2015 AAC..
04/16 QIAGEN NV : N.V. : to Report First Quarter 2015 Results
04/16 Receptos Reports Positive Results for the Maintenance Period of the Phase 2 T..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
04/02 Shire - Kyle Bass's 2nd Target
03/25 NEW PATENT LEGISLATION : Impacts On Publicly-Traded Patent Investments
03/18 Not In Favor Of The Solar Industry - Cramer's Lightning Round (3/17/15)
02/26 New Parkinson's drug cleared in Europe
02/24 ACORDA 2015 : Patents, Pipeline And Patients; Cash And Catalysts


Comments 
Advertisement
Chart ACORDA THERAPEUTICS INC
Duration : Period :
Acorda Therapeutics Inc Technical Analysis Chart | ACOR | US00484M1062 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF